This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Aging/ Geriatrics  • Medical Practice  • Medical Ethics  • Genetics  • Genetic Counseling/ Testing/ Therapy  • Alert me on articles by topic  Social Bookmarking   What's this?

Edited by Catherine Y. Read, Robert C. Green, and Michael A. Smyer
296 pp, $45.50
Baltimore, MD, Johns Hopkins University Press, 2008
ISBN-13: 978-0-8018-8788-8

JAMA. 2009;302(1):94-95.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

It is common knowledge that, in nearly all developed countries, the number of persons older than 65 years is increasing, both in absolute terms and as a proportion of the general population. By some estimates, the number of those older than 65 years will double in the United States in the next 2 decades. While there have always been attempts to prolong longevity, there is now an increased interest—and ability—to improve the quality of those added years. Aging, Biotechnology, and the Future is based on a forum held in 2005 that was sponsored by the National Institute on Aging and the Jesuit Institute of Boston College and that drew scholars from the fields of medicine, law, biology, psychology, gerontology, nursing, philosophy, ethics, and religion. The focus was on the intersection of biotechnology and aging and on how new technologies can affect the life span and the concerns of aging.

The . . . [Full Text of this Article]

David L. Streiner, PhD, CPsych, Reviewer
Department of Psychiatry
University of Toronto
Toronto, Ontario, Canada
dstreiner@klaru-baycrest.on.ca

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?